A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096 · cited 1×
“They are also in agreement with the data of two recent meta-analyses [20, 21], which included the data of this study [8].”
ResultGlucose Control and Mortality in Critically Ill Patients
Finney, S. J. (2003) · JAMA · doi:10.1001/jama.290.15.2041 · Cited by 1,055
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872 · cited 1×
“insulin [28].”
Severe hypoglycemia in critically ill patients: risk factors and outcomes
Krinsley, J. S., & Grover, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282073.98414.4b · Cited by 671 · cited 2×
“Secondly, associated risks of IIT included hypoglycaemia, implying increases in workload and stress [4], and potential complications [5].”
BackgroundGandhi, G. Y., Nuttall, G. A., Abel, M. D., Mullany, C. J., Schaff, H. V., O'Brien, P. C., Johnson, M. G., Williams, A. R., Cutshall, S. M., Mundy, L. M., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-4-200702200-00002 · Cited by 607
Hyperglycaemic index as a tool to assess glucose control: a retrospective study
Vogelzang, M., van der Horst, I. C., & Nijsten, M. W. (2004) · Critical Care · doi:10.1186/cc2840 · Cited by 507
Implementation of a Safe and Effective Insulin Infusion Protocol in a Medical Intensive Care Unit
Goldberg, P. A., Siegel, M. D., Sherwin, R. S., Halickman, J. I., Lee, M., Bailey, V. A., Lee, S. L., Dziura, J. D., & Inzucchi, S. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.461 · Cited by 483 · cited 1×
“Thereby, accurate assessment of time in target allowed, more precisely than by the use of morning values only [1, 6, 7, 14, 18, 33–36].”
BackgroundArabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f21aa · Cited by 471 · cited 3×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
MethodResultReliability of point-of-care testing for glucose measurement in critically ill adults*
Kanji, S., Buffie, J., Hutton, B., Bunting, P. S., Singh, A., McDonald, K., Fergusson, D., McIntyre, L. A., & Hebert, P. C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000189939.10881.60 · Cited by 395 · cited 1×
“To avoid excessive heterogeneity and inaccuracy in the measurement of glucose concentration, only a validated model of glucose analyser was allowed [37].”
MethodManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Aragon, D. (2006) · American Journal of Critical Care · doi:10.4037/ajcc2006.15.4.370 · Cited by 370 · cited 1×
“Secondly, associated risks of IIT included hypoglycaemia, implying increases in workload and stress [4], and potential complications [5].”
BackgroundHypoglycemia, functional brain failure, and brain death.
Cryer, P. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31669 · Cited by 363
Vespa, P., Boonyaputthikul, R., McArthur, D. L., Miller, C., Etchepare, M., Bergsneider, M., Glenn, T., Martin, N., & Hovda, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201875.12245.6f · Cited by 343
De La Rosa, G. D. C., Donado, J. H., Restrepo, A. H., Quintero, A. M., González, L. G., Saldarriaga, N. E., Bedoya, M., Toro, J. M., Velásquez, J. B., Valencia, J. C., et al. (2008) · Critical Care · doi:10.1186/cc7017 · Cited by 319
Early Insulin Therapy in Very-Low-Birth-Weight Infants
Beardsall, K., Vanhaesebrouck, S., Ogilvy-Stuart, A. L., Vanhole, C., Palmer, C. R., van Weissenbruch, M., Midgley, P., Thompson, M., Thio, M., Cornette, L., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803725 · Cited by 310 · cited 1×
“include the frequency of BG checks [29] and the degree Table 3 coninued”
BackgroundReduction of Nosocomial Infections in the Surgical Intensive-Care Unit by Strict Glycemic Control
Grey, N. J., & Perdrizet, G. A. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.46 · Cited by 258 · cited 2×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
ResultKanji, S., Singh, A., Tierney, M., Meggison, H., McIntyre, L., & Hebert, P. C. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2252-2 · Cited by 208 · cited 1×
“The variations in the number of patients recruited in each centre [35], potentially influenced the results: after exclusion of the patients”
ResultBenefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
Intensive insulin therapy and mortality in critically ill patients
Treggiari, M. M., Karir, V., Yanez, N. D., Weiss, N. S., Daniel, S., & Deem, S. A. (2008) · Critical Care · doi:10.1186/cc6807 · Cited by 160 · cited 1×
“1 mmol/L reported in other prospective trials [1, 13], but confirm the findings by others [7, 14–19], who failed to show any benefit from IIT.”
ResultWalters, M. R., Weir, C. J., & Lees, K. R. (2006) · Cerebrovascular Diseases · doi:10.1159/000093239 · Cited by 128 · cited 1×
“1 mmol/L reported in other prospective trials [1, 13], but confirm the findings by others [7, 14–19], who failed to show any benefit from IIT.”
ResultAn Insulin Infusion Protocol in Critically Ill Cardiothoracic Surgery Patients
Zimmerman, C. R., Mlynarek, M. E., Jordan, J., Rajda, C. A., & Horst, H. M. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e018 · Cited by 128 · cited 1×
“Thereby, accurate assessment of time in target allowed, more precisely than by the use of morning values only [1, 6, 7, 14, 18, 33–36].”
BackgroundIntensive Insulin Therapy in Critical Illness
Angus, D. C., & Abraham, E. H. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2508009 · Cited by 95 · cited 1×
“Several issues might limit the external validity of the benefits of IIT [2, 3].”
BackgroundAhrens, C. L., Barletta, J. F., Kanji, S., Tyburski, J. G., Wilson, R. F., Janisse, J. J., & Devlin, J. W. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186746.64572.8a · Cited by 92 · cited 1×
“Similarly, the average dose of insulin was lower, reflecting the marked hyperglycaemic effect of parenteral glucose [26, 27].”
Backgroundvan der Voort, P. H. J., Feenstra, R., Bakker, A. J., de Heide, L., Boerma, E. C., & van der Horst, I. C. C. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02437.x · Cited by 72 · cited 2×
“Similarly, the average dose of insulin was lower, reflecting the marked hyperglycaemic effect of parenteral glucose [26, 27].”
BackgroundResultCurrent controversies around tight glucose control in critically ill patients
Devos, P., & Preiser, J. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3280147d2d · Cited by 69 · cited 2×
“observations made in a highly experienced centre may translate to others is presently unknown [3].”
BackgroundSelf-citationMitchell, I., Knight, E., Gissane, J., Tamhane, R., Kolli, R., Leditschke, I. A., Bellomo, R., & Finfer, S. R. (2006) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)02060-4 · Cited by 53
Steps for the implementation and validationof tight glucose control
Preiser, J., & Devos, P. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0485-y · Cited by 22 · cited 1×
“Thereby, accurate assessment of time in target allowed, more precisely than by the use of morning values only [1, 6, 7, 14, 18, 33–36].”
BackgroundSelf-citation
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationThe Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“The continuation of insulin infusions, especially with the cessation of nutrition, has been identified as a risk factor for hypoglycemia [454].”
BackgroundSelf-citationSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.